In the present issue of Intensive Care Medicine, OspinaTascón et al. present an intriguing observational study in which they assessed the association between venous-toarterial carbon dioxide difference (Pv-aCO 2 ) and microvascular perfusion in patients with early septic shock [1] . A total of 75 adult patients with septic shock from a 60-bed mixed ICU in Columbia were included in the study. Potentially eligible patients with septic shock in the ICU were screened, and those eligible had a pulmonary artery catheter (PAC) inserted and were included in the study. Arterial and mixed venous blood samples were collected at the insertion of the PAC (T0) and at 6 h (T6), and Pv-aCO 2 was defined as the difference between mixed-venous and arterial CO 2 partial pressures. A sidestream dark-field imaging device was used to evaluate the microcirculation of the tongue at T0 and T6, and the association between Pv-aCO 2 and the microcirculation of the tongue was assessed. Furthermore, the association between Pv-aCO 2 and global haemodynamic variables was evaluated. The authors conclude that Pv-aCO 2 was closely related to microcirculatory blood flow parameters during the early phase of septic shock, whereas Pv-aCO 2 was poorly related to systemic haemodynamic variables [1] .
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Septic shock is a serious and frequent condition in the ICU, and early recognition and adequate treatment of tissue hypoperfusion is crucial [2, 3] . Oxygen-derived parameters such as central venous oxygen saturation (ScVO 2 ) have failed to demonstrate clinical benefit as resuscitation targets in recent large randomised controlled trials and systematic reviews [4] [5] [6] . Mean baseline ScVO 2 was above 70 % in all the trials, which may be explained by early recognition and aggressive treatment of shock. Nevertheless, while a low ScVO 2 can prompt further resuscitation [3] , in the context of normal or high ScVO 2 its role is more questionable. Indeed, one of the limitations of using ScVO 2 as a marker of hypoperfusion is that normal to high values cannot discriminate whether oxygen delivery is adequate or in excess of demand. High ScVO 2 in the context of high lactate has for instance been shown to be associated with poor survival rates [7] . In this situation other tissue perfusion variables such as Pv-aCO 2 have been proposed [8, 9] . In normal circumstances the difference between the arterial and the venous carbon dioxide is less than 6 mmHg. However, in states of low perfusion this difference can increase. In areas of the microcirculation that are poorly perfused there is an increased local production of CO 2 . Despite poor perfusion, since CO 2 is about 20 times more soluble than O 2 , the likelihood of CO 2 diffusing out of ischemic tissues and into the venous effluent is high, making it a very sensitive marker of hypoperfusion. Vallée et al. demonstrated that in septic patients with normalized ScVO 2 , high central venous-to-arterial CO 2 difference (PcvaCO 2 ) was associated with worse outcomes in terms of lower lactate clearance, lower cardiac index, and higher sepsis-related organ failure assessment (SOFA) score [8] . Ospina-Tascón et al.'s study adds to the evidence that P(c)v-aCO 2 may be a useful tool to identify patients who remain inadequately resuscitated when an ScVO 2 of 70 % has been reached [10] . Consequently, Pv-aCO 2 may prove useful in the assessment of patients with shock (Fig. 1) .
While there seems to be convincing evidence that P(c)v-aCO 2 is a marker of (microcirculatory) hypoperfusion, a number of unanswered questions and limitations regarding routine clinical bedside use of Pv-aCO 2 exist. First, use of Pv-aCO 2 has not been tested in (randomised) clinical trials. Consequently, there is a risk of falsely inflated estimates [11] , and the balance between benefits and harms are unknown. Second, there is a lack of PvaCO 2 studies assessing patient-important outcome measures with adequate follow-up [12] . Trials using nonpatient-important outcome measures (surrogate outcomes) overestimate the intervention effect by 40-50 % [13] . Third, existing studies have mainly been conducted in small single-centre institutions, which increases the risk of reporting falsely inflated estimates [14, 15] . Finally, the unblinded assessment of the association between Pv-aCO 2 and the microcirculation increases the risk of selection bias [15] .
In conclusion, Pv-aCO 2 is an interesting and potentially important new tool for evaluation of the microcirculation in critically ill patients with shock; however, additional clinical evaluation, including adequate assessment of benefits and harms in high-quality randomised clinical trials, is needed prior to routine clinical use at the bedside.
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